Additional investments planned to expand the site’s capacity and capabilities to support growing manufacturing programs
The study is being conducted under a USFDA IND, has received U.S. Fast Track Designation for SLE-ITP, and has obtained IND approval from China’s Center for Drug Evaluation
The company also revealed that MK-2214 has received Fast Track Designation from the U.S. Food and Drug Administration
The trial will evaluate safety endpoints including dose-limiting toxicities and adverse events
New study presents a human-relevant stress model for assessing potential therapeutics
Both of Moderna's COVID-19 vaccines for the 2025-2026 season have demonstrated strong immune responses against today's top circulating COVID-19 strains
Protein L is known as a “superantigen” because it can bind antibodies in unusual ways
Phase 1 dosing is expected to finish by the end of 2025
He has previously served in pivotal HR leadership roles at RPG Life Sciences, Akumentis Healthcare, and Wockhardt
Orion will be the exclusive partner for the distribution, marketing, and sales of Shilpa's Recombinant Human Albumin in Europe
Subscribe To Our Newsletter & Stay Updated
